Butyrate producing gut bacteria increases immunity producing T cells

Gut bacteria increases immunity

10:59 AM, 18th November 2013
Gut bacteria fights bowel diseases increase immunity
In a mouse model for experimental colitis, a diet supplemented with butyric acid leads to decreased infiltration of inflammatory cells.

SAITAMA, JAPAN: New research from the RIKEN Centre for Integrative Medical Sciences in Japan sheds light on the role of gut bacteria on the maturation of the immune system and provides evidence supporting the use of butyrate as therapy for inflammatory bowel diseases like Crohn’s disease.

The study shows that butyrate, a by-product of the digestion of dietary fibre by gut microbes, acts as an epigenetic switch that boosts the immune system by inducing the production of regulatory T cells in the gut. Previous studies have shown that patients suffering from inflammatory bowel disease lack butyrate-producing bacteria and have lower levels of butyrate in their gut. However, butyrate’s anti-inflammatory properties were attributed to its role as main energy source for the cells lining the colon. This study is the first to provide a molecular basis for the role of butyrate on the production of regulatory T lymphocytes.

The Japanese team, lead by Dr Hiroshi Ohno from RIKEN in collaboration with the University of Tokyo and Keio University, investigated the molecular mechanisms by which commensal microbes augment the number of regulatory T cells (Treg cells) present in the colon of mice that were bred germ-free.

The research demonstrates that butyric acid, a short-chain fatty acid produced by commensal bacteria acts on naïve T cells to promote their differentiation into Treg cells. It achieves this through epigenetic changes that regulate the expression of the genes responsible for differentiation of naïve T cells into Treg cells.

The study shows that mice suffering from colitis see their levels of Treg cells increase and their symptoms improve after administration of butyrate as part of their diet.

“Regulatory T cells are important for the containment of excessive inflammatory responses as well as autoimmune disorders. Therefore these findings could be applicable for the prevention and treatment of inflammatory bowel disease (IBD), allergy and autoimmune disease. Butyrate is natural and safe as a therapy and in addition to that it is cheap, which could reduce costs for both patients and society,” Dr Hiroshi Ohno.

© RIKEN News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Mitsui acquires PTA manufacturer in Indonesia

TOKYO, JAPAN: Mitsui Chemicals Inc agreed to transfer all shares in P T Amoco Mitsui PTA Indonesia, a manufacturer of purified terephthalic acid (PTA) ...

Read more
RIL appoints new independent director, Adil Zainulbhai

MUMBAI, INDIA: Reliance Industries Limited (RIL) appointed Adil Zainulbhai as an Independent Director on the Board with immediate effect. With this th ...

Read more
Methods of preparation of caustic soda

SINGAPORE: Sodium hydroxide, also known as caustic soda or lye, is an inorganic compound with the chemical formula NaOH. It is a white solid, and is a ...

Read more
Metabolix appoints new President and CEO, Joseph Shaulson

CAMBRIDGE, US: Metabolix Inc has appointed Joseph Shaulson as its new President and Chief Executive Officer (CEO) effective from 2 January 2014 and as ...

Read more
Towards development of insulin pills

WASHINGTON DC, US: Discovery of Insulin has saved the life of many people around the world. Now scientists are reporting a new development toward a lo ...

Read more
Axiall to build ethylene cracker in Louisiana, US

ATLANTA, US: Axiall Corporation plans to build ethylene cracker in conjunction with a related derivatives plant in the US state of Louisiana. Axiall p ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X